Breaking News Instant updates and real-time market news.

2021-01-27 11:13:21 VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) , LLY Eli Lilly $208.50 / -4.4 (-2.07%) … 11:13 01/27/21 01/27 11:13 01/27/21 11:13	Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program After Vir Biotechnology (VIR), Eli Lilly (LLY) and GlaxoSmithKline (GSK) announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild-to-moderate COVID-19, H.C. Wainwright analyst Patrick Trucchio noted that Vir said this is the first time that monoclonal antibodies from separate companies are being brought together in this way to explore potential outcomes. The analyst, who thinks other mAb developers may also consider combining their therapies with Vir's, said the collaboration gives him increased confidence in Vir's COVID-19 program. Trucchio reiterates a Buy and $125 price target on Vir shares following this morning's announcement. VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) LLY Eli Lilly $208.50 / -4.4 (-2.07%) GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%)	27 Jan 29 Jan 03 Feb 01 Mar 02 Mar 08 Jul
VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 01/27/21 JPMorgan Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan 01/27/21 JPMorgan Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan 01/20/21 H.C. Wainwright Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright 12/24/20 Baird Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse

2021-01-27 11:13:21

VIR

Vir Biotechnology

$114.48 / +37.99 (+49.67%)

, LLY

Eli Lilly

$208.50 / -4.4 (-2.07%)

… 11:13

01/27/21

01/27

11:13

01/27/21

11:13

Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program

After Vir Biotechnology (VIR), Eli Lilly (LLY) and GlaxoSmithKline (GSK) announced a collaboration to evaluate a combination of two COVID-19 therapies in low-risk patients with mild-to-moderate COVID-19, H.C. Wainwright analyst Patrick Trucchio noted that Vir said this is the first time that monoclonal antibodies from separate companies are being brought together in this way to explore potential outcomes. The analyst, who thinks other mAb developers may also consider combining their therapies with Vir's, said the collaboration gives him increased confidence in Vir's COVID-19 program. Trucchio reiterates a Buy and $125 price target on Vir shares following this morning's announcement.

VIR

Vir Biotechnology

$114.48 / +37.99 (+49.67%)

LLY

Eli Lilly

$208.50 / -4.4 (-2.07%)

GSK

GlaxoSmithKline

$38.73 / -0.515 (-1.31%)

27
Jan
29
Jan
03
Feb
01
Mar
02
Mar

08
Jul

VIR Vir Biotechnology

$114.48 / +37.99 (+49.67%)

01/27/21 JPMorgan: Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan

01/27/21 JPMorgan: Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan

01/20/21 H.C. Wainwright: Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright

12/24/20 Baird: Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data

LLY Eli Lilly

$208.50 / -4.4 (-2.07%)

01/26/21 Berenberg: Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg

01/20/21 Citi: Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data

01/19/21 Roth Capital: Merus price target raised to $32 from $19 at Roth Capital

01/19/21: Fly Intel: Top five analyst upgrades

GSK GlaxoSmithKline

$38.73 / -0.515 (-1.31%)

01/26/21 Piper Sandler: Amarin in 'strong position' against Health Net, says Piper Sandler

01/20/21 UBS: GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS

01/20/21: Fly Intel: Top five analyst downgrades

01/20/21 Credit Suisse: GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse

TODAY'S FREE FLY STORIES

Downgrade	World Fuel Services downgraded to Hold from Buy at Stifel » 05:34 02/26/21 02/26 05:34 02/26/21 05:34 INT World Fuel Services $34.92 / -1 (-2.78%) Stifel analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings INT World Fuel Services $34.92 / -1 (-2.78%) 01/19/21 BofA World Fuel Services upgraded to Buy from Underperform at BofA 02/28/20 Stifel World Fuel Services price target lowered to $43 from $46 at Stifel INT World Fuel Services $34.92 / -1 (-2.78%) 02/25/21 World Fuel Services reports Q4 EPS 2c, two estimates 23c
Upgrade	L Brands upgraded to Overweight from Equal Weight at Morgan Stanley » 05:34 02/26/21 02/26 05:34 02/26/21 05:34 LB L Brands $52.45 / +0.8 (+1.55%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LB L Brands $52.45 / +0.8 (+1.55%) 02/25/21 Alliance Data partners with Victoria's Secret on private label credit card 02/24/21 L Brands continuing to work toward separation of the two businesses 02/24/21 L Brands sees Q1 gross margin up 'significantly' 02/24/21 L Brands 'pleased' with February's results LB L Brands $52.45 / +0.8 (+1.55%) 02/25/21 Wells Fargo L Brands price target raised to $75 from $66 at Wells Fargo 02/25/21 Deutsche Bank L Brands price target raised to $77 from $61 at Deutsche Bank 02/18/21 UBS L Brands price target raised to $54 from $46 at UBS 02/16/21 Jefferies L Brands assumed with a Hold at Jefferies LB L Brands $52.45 / +0.8 (+1.55%) 02/24/21 L Brands sees Q1 sales 'roughly flat' with last year's $2.6B 02/24/21 L Brands sees Q1 EPS 35c-45c, consensus 12c 02/24/21 L Brands reports Q4 EPS $3.03, consensus $2.91 02/24/21 Notable companies reporting after market close LB L Brands $52.45 / +0.8 (+1.55%) 11/18/20 Second investigation begins at Victoria's Secret over Epstein ties, NYT reports LB L Brands $52.45 / +0.8 (+1.55%) 02/24/21 Fly Intel: After-Hours Movers 02/16/21 American Express downgrade among today's top calls on Wall Street 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday 05/20/21 L Brands - LB LB L Brands $52.45 / +0.8 (+1.55%) 02/25/21 Early notable gainers among liquid option names on February 25th 02/04/21 Early notable gainers among liquid option names on February 4th 01/25/21 L Brands put volume heavy and directionally bearish 12/07/20 Early notable gainers among liquid option names on December 7th
Downgrade	Krones downgraded to Hold from Buy at HSBC » 05:34 02/26/21 02/26 05:34 02/26/21 05:34 KRNTY Krones / + HSBC analyst Richard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KRNTY Krones / + 02/16/21 UBS Krones price target raised to EUR 89 from EUR 81 at UBS 10/02/20 HSBC HSBC upgrades Krones to Buy on order intake recovery 10/02/20 HSBC Krones upgraded to Buy from Hold at HSBC 08/04/20 DZ Bank Krones upgraded to Buy from Hold at DZ Bank
Downgrade	Pinnacle Renewable downgraded to Hold from Buy at Desjardins » 05:33 02/26/21 02/26 05:33 02/26/21 05:33 PINWF Pinnacle Renewable $0.00 / + (+0.00%) Desjardins analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research PINWF Pinnacle Renewable $0.00 / + (+0.00%) 02/08/21 Drax to acquire Pinnacle Renewable for C$11.30 per share PINWF Pinnacle Renewable $0.00 / + (+0.00%) 02/09/21 BMO Capital Pinnacle Renewable price target raised to C$11.30 from C$9 at BMO Capital 02/09/21 TD Securities Pinnacle Renewable downgraded to Hold from Buy at TD Securities 02/09/21 Stifel Pinnacle Renewable downgraded to Hold from Buy at Stifel 01/13/21 CIBC Pinnacle Renewable price target raised to C$12 from C$10 at CIBC
Hot Stocks	Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B » 05:33 02/26/21 02/26 05:33 02/26/21 05:33 TAK Takeda Pharmaceutical $16.75 / -0.48 (-2.79%) Takeda Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals Events Options TAK Takeda Pharmaceutical $16.75 / -0.48 (-2.79%) 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/12/21 Takeda Pharmaceutical's maribavir Phase 3 clinical trial met primary endpoint 02/10/21 Takeda Pharmaceutical submits new drug application for darvadstrocel in Japan 01/28/21 Takeda presents results for mobocertinib in patients with EGFR Exon20 insertion TAK Takeda Pharmaceutical $16.75 / -0.48 (-2.79%) 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham 06/18/20 RBC Capital Neurocrine price target raised to $135 from $116 at RBC Capital TAK Takeda Pharmaceutical $16.75 / -0.48 (-2.79%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports 09/01/20 NIH says not enough evidence to recommend convalescent plasma, Bloomberg reports 09/01/20 NIH panel says data fail to back EUA for convalescent plasma, Bloomberg reports 03/01/21 41st Annual Healthcare Virtual Conference TAK Takeda Pharmaceutical $16.75 / -0.48 (-2.79%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish

Upgrade	HP Inc. upgraded to Overweight from Neutral at JPMorgan » 05:32 02/26/21 02/26 05:32 02/26/21 05:32 HPQ HP Inc. $28.21 / +0.235 (+0.84%) JPMorgan analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HPQ HP Inc. $28.21 / +0.235 (+0.84%) 02/25/21 HP Inc. up 4% to $29.18 after earlier-than-anticipated earnings release 02/25/21 HP Inc. trading resumes 02/25/21 HP Inc. trading halted, news pending 02/25/21 HP Inc. up 5% to $29.42 in afternoon trading HPQ HP Inc. $28.21 / +0.235 (+0.84%) 02/24/21 JPMorgan HP Inc. price target raised to $28 from $26 at JPMorgan 02/23/21 Deutsche Bank HP Inc. price target raised to $26 from $21 at Deutsche Bank 01/14/21 Barclays HP downgraded to Underweight on near-term concerns at Barclays 01/14/21 Barclays HP Inc. downgraded to Underweight from Equal Weight at Barclays HPQ HP Inc. $28.21 / +0.235 (+0.84%) 02/25/21 HP Inc. sees FY21 EPS $3.15-$3.25, consensus $2.65 02/25/21 HP Inc. sees Q2 EPS 84c-90c, consensus 61c 02/25/21 HP Inc. reports Q1 EPS 92c, consensus 66c 02/25/21 Notable companies reporting after market close HPQ HP Inc. $28.21 / +0.235 (+0.84%) 11/25/20 Fly Intel: Wall Street's top stories for Wednesday 11/25/20 Fly Intel: Wall Street's top stories at midday 11/25/20 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: After-Hours Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/13/21 HP Inc. HPQ HP Inc. $28.21 / +0.235 (+0.84%) 11/30/20 HP Inc. put volume heavy and directionally bearish 11/25/20 HP Inc. call volume above normal and directionally bullish 11/25/20 Early notable gainers among liquid option names on November 25th 11/24/20 HP Inc. options imply 6.9% move in share price post-earnings
Downgrade	Solar Capital downgraded to Neutral from Overweight at JPMorgan » 05:32 02/26/21 02/26 05:32 02/26/21 05:32 SLRC Solar Capital $19.12 / -0.07 (-0.36%) JPMorgan analyst Richard… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SLRC Solar Capital $19.12 / -0.07 (-0.36%) 02/24/21 Solar Capital to change name to SLR Capital Partners, effective February 25 SLRC Solar Capital $19.12 / -0.07 (-0.36%) 11/24/20 Compass Point Solar Capital downgraded to Neutral from Buy at Compass Point 11/10/20 Wells Fargo Solar Capital downgraded to Equal Weight on fee structure at Wells Fargo 11/10/20 Wells Fargo Solar Capital downgraded to Equal Weight from Overweight at Wells Fargo 08/07/20 Ladenburg Solar Capital upgraded to Buy from Neutral at Ladenburg SLRC Solar Capital $19.12 / -0.07 (-0.36%) 02/24/21 Solar Capital reports Q4 EPS 43c, consensus 35c 11/05/20 Solar Capital reports Q3 EPS 44c, consensus 35c
Upgrade	Owl Rock upgraded to Outperform from Sector Perform at RBC Capital » 05:31 02/26/21 02/26 05:31 02/26/21 05:31 ORCC Owl Rock $13.77 / -0.15 (-1.08%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ORCC Owl Rock $13.77 / -0.15 (-1.08%) 02/24/21 ISS, Glass Lewis recommend Owl Rock shareholders vote for meeting proposals 02/16/21 Cooperman's Omega Advisors buys GM, exits Lee in Q4 12/03/20 Owl Rock, Dyal Capital confirm merger talks with Altimar Acquisition ORCC Owl Rock $13.77 / -0.15 (-1.08%) 02/24/21 Janney Montgomery Scott Owl Rock upgraded to Buy from Neutral at Janney Montgomery Scott 11/06/20 Ladenburg Owl Rock upgraded to Buy after earnings at Ladenburg 11/06/20 Ladenburg Owl Rock upgraded to Buy from Neutral at Ladenburg 11/05/20 Compass Point Compass Point upgrades Owl Rock to Buy with BDC 'passing the credit test' ORCC Owl Rock $13.77 / -0.15 (-1.08%) 02/23/21 Owl Rock reports Q4 EPS 29c, consensus 27c 11/04/20 Owl Rock reports Q3 NII 33c, consensus 35c 03/17/21 Owl Rock Capital Corporation ORCC Owl Rock $13.77 / -0.15 (-1.08%) 11/02/20 Nine new option listings and four option delistings on November 2nd
Upgrade	Canfor Pulp upgraded to Outperform from Sector Perform at RBC Capital » 05:30 02/26/21 02/26 05:30 02/26/21 05:30 CFPUF Canfor Pulp $0.00 / + (+0.00%) RBC Capital analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CFPUF Canfor Pulp $0.00 / + (+0.00%) 02/25/21 Raymond James Canfor Pulp price target raised to C$13.50 from C$9.50 at Raymond James 02/25/21 Scotiabank Canfor Pulp price target raised to C$7 from C$6.50 at Scotiabank 02/09/21 Scotiabank Canfor Pulp price target raised to C$6.50 from C$6 at Scotiabank 12/18/20 CIBC Canfor Pulp price target raised to C$8.50 from C$5.50 at CIBC
Hot Stocks	Incyte announces EMA validation of retifanlimab MAA » 05:29 02/26/21 02/26 05:29 02/26/21 05:29 INCY Incyte $78.44 / -2.17 (-2.69%) Incyte announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options INCY Incyte $78.44 / -2.17 (-2.69%) 02/22/21 Incyte announces FDA acceptance, priority review for ruxolitinib sNDA 02/19/21 Incyte announces acceptance, priority review for ruxolitinib cream NDA 02/09/21 Incyte sees FY21 Jakafi revenue $2.13B-$2.2B 01/29/21 Incyte announces positive CHMP opinion for pemigatinib INCY Incyte $78.44 / -2.17 (-2.69%) 02/10/21 SVB Leerink Incyte downgraded to Market Perform from Outperform at SVB Leerink 01/07/21 Truist Incyte initiated with a Buy at Truist 01/07/21 Truist Incyte initiated with a Buy at Truist 01/04/21 Guggenheim Incyte upgraded to Buy from Neutral at Guggenheim INCY Incyte $78.44 / -2.17 (-2.69%) 02/09/21 Incyte reports Q4 EPS 93c, consensus 75c 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open 11/05/20 Incyte reports Q3 EPS 23c, consensus 75c INCY Incyte $78.44 / -2.17 (-2.69%) 02/09/21 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference 07/25/21 PDUFA Date for Retifanlimab INCY Incyte $78.44 / -2.17 (-2.69%) 01/22/21 Early notable gainers among liquid option names on January 22nd 12/14/20 Early notable gainers among liquid option names on December 14th

Upgrade	Carvana upgraded to Overweight from Equal Weight at Morgan Stanley » 05:29 02/26/21 02/26 05:29 02/26/21 05:29 CVNA Carvana $263.11 / -21.81 (-7.65%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options CVNA Carvana $263.11 / -21.81 (-7.65%) 02/25/21 Carvana says expect to accelerate growth in retail units sold 02/16/21 Lone Pine bought Snap and Carvana during Q4, exited PayPal 02/03/21 Carvana launches home delivery to Alexandria area residents 11/20/20 Ford to launch used vehicle platform Ford Blue Advantage CVNA Carvana $263.11 / -21.81 (-7.65%) 02/24/21 Jefferies Carvana well positioned for 'beat/raise' earnings report, says Jefferies 02/23/21 Cowen Carvana price target raised to $336 from $250 at Cowen 02/16/21 Baird Carvana price target raised to $325 from $285 at Baird 01/29/21 Jefferies Carvana, Walmart among 13 additions to Jefferies Franchise Picks list CVNA Carvana $263.11 / -21.81 (-7.65%) 02/25/21 Carvana reports Q4 EPS (87c), consensus (47c) 02/25/21 Notable companies reporting after market close 10/29/20 Carvana not providing FY20 guidance, positioning for strong growth in 2021 10/29/20 Carvana reports Q3 EPS (10c), consensus (33c) 02 Dec 19 May CVNA Carvana $263.11 / -21.81 (-7.65%) 02/25/21 Fly Intel: After-Hours Movers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/15/20 Wells Fargo upgrade, Dick's Sporting initiation among top calls on Wall Street 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street CVNA Carvana $263.11 / -21.81 (-7.65%) 12/02/20 Carvana put volume heavy and directionally bearish 09/24/20 Carvana put volume heavy and directionally bearish 09/22/20 Unusually active option classes on open September 22nd 09/14/20 Carvana put volume heavy and directionally bearish
Downgrade	Subsea 7 downgraded to Hold from Buy at SEB Equities » 05:28 02/26/21 02/26 05:28 02/26/21 05:28 SUBCY Subsea 7 $0.00 / + (+0.00%) SEB Equities analyst Kim… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SUBCY Subsea 7 $0.00 / + (+0.00%) 02/18/21 Jefferies Subsea 7 downgraded to Hold from Buy at Jefferies 01/19/21 Morgan Stanley Subsea 7 downgraded to Equal Weight from Overweight at Morgan Stanley 01/06/21 JPMorgan Subsea 7 price target raised to NOK 107 from NOK 97 at JPMorgan 12/15/20 Credit Suisse Subsea 7 price target raised to NOK 99 from NOK 86 at Credit Suisse
Upgrade	HSBC upgraded to Reduce from Add at AlphaValue » 05:28 02/26/21 02/26 05:28 02/26/21 05:28 HSBC HSBC $30.17 / -0.185 (-0.61%) AlphaValue upgraded HSBC… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HSBC HSBC $30.17 / -0.185 (-0.61%) 01/15/21 Chubb CFO Philip Bancroft to retire, Peter Enns to succeed 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 11/29/20 Fly Intel: Top five weekend stock stories HSBC HSBC $30.17 / -0.185 (-0.61%) 05:26 Today Societe Generale HSBC upgraded to Hold from Sell at Societe Generale 02/25/21 Berenberg HSBC price target raised to 400 GBp from 380 GBp at Berenberg 02/24/21 Barclays HSBC price target raised to 440 GBp from 400 GBp at Barclays 02/24/21 Credit Suisse HSBC price target raised to 400 GBp from 370 GBp at Credit Suisse HSBC HSBC $30.17 / -0.185 (-0.61%) 10/27/20 HSBC reports Q3 EPS 7c vs. 15c last year HSBC HSBC $30.17 / -0.185 (-0.61%) 02/19/21 HSBC doesn't have to hand over documents to Huawei CFO, WSJ reports 01/27/21 U.K. taps HSBC, JPMorgan to advise on first 'green' bond, Reuters says 01/10/21 HSBC to face shareholder heat on fossil fuels in AGM vote, Reuters says 11/29/20 HSBC considers exit from U.S. retail banking, FT reports HSBC HSBC $30.17 / -0.185 (-0.61%) 10/16/20 The Intersection: Crypto and Wall Street This Week 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 09/21/20 Fly Intel: Pre-market Movers HSBC HSBC $30.17 / -0.185 (-0.61%) 01/07/21 HSBC call volume above normal and directionally bullish 12/09/20 Unusually active option classes on open December 9th 12/04/20 Unusually active option classes on open December 4th 11/09/20 HSBC call volume above normal and directionally bullish
Downgrade	Voyager Therapeutics downgraded to Neutral from Outperform at Baird » 05:27 02/26/21 02/26 05:27 02/26/21 05:27 VYGR Voyager Therapeutics $6.22 / -0.37 (-5.61%) Baird analyst Brian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events VYGR Voyager Therapeutics $6.22 / -0.37 (-5.61%) 02/02/21 Voyager Therapeutics says Neurocrine terminates Parkinson's part of agreement 12/22/20 Voyager says clinical hold placed on RESTOR-1 clinical trial of NBIb-1817 10/12/20 Voyager Therapeutics provides update on VY-HTT01 IND 09/14/20 Voyager Therapeutics names Michelle Quinn Smith chief HR officer VYGR Voyager Therapeutics $6.22 / -0.37 (-5.61%) 02/03/21 Wedbush Voyager Therapeutics downgraded to Neutral at Wedbush 02/03/21 Wedbush Voyager Therapeutics downgraded to Neutral from Outperform at Wedbush 02/03/21 Morgan Stanley Voyager Therapeutics price target lowered to $7 from $13 at Morgan Stanley 02/03/21 BTIG Voyager Therapeutics downgraded to Neutral from Buy at BTIG VYGR Voyager Therapeutics $6.22 / -0.37 (-5.61%) 02/25/21 Voyager Therapeutics reports Q4 EPS (43c), consensus (56c) 11/09/20 Voyager Therapeutics reports Q3 EPS $2.27, consensus (19c) VYGR Voyager Therapeutics $6.22 / -0.37 (-5.61%) 02/03/21 Fly Intel: Pre-market Movers 12/23/20 Fly Intel: Pre-market Movers 12/22/20 Fly Intel: After-Hours Movers 10/12/20 Fly Intel: After-Hours Movers 03/01/21 41st Annual Healthcare Virtual Conference
Downgrade	WNS Holdings downgraded to Neutral from Outperform at Baird » 05:27 02/26/21 02/26 05:27 02/26/21 05:27 WNS WNS Holdings $76.98 / +0.21 (+0.27%) Baird analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings WNS WNS Holdings $76.98 / +0.21 (+0.27%) 12/11/20 WNS Holdings extends partnership with Scandinavian Airlines System 10/15/20 WNS Holdings CEO says 'visibility has now improved' WNS WNS Holdings $76.98 / +0.21 (+0.27%) 01/22/21 Barrington WNS Holdings price target raised to $84 from $76 at Barrington 01/22/21 Cowen WNS Holdings price target raised to $80 from $76 at Cowen 01/21/21 Needham WNS Holdings price target raised to $85 from $78 at Needham 12/30/20 William Blair WNS overlooked by investors due to travel exposure, says William Blair WNS WNS Holdings $76.98 / +0.21 (+0.27%) 01/21/21 WNS Holdings sees FY21 adjusted EPS $2.61-$2.73, consensus $2.46 01/21/21 WNS Holdings reports Q3 adjusted EPS 79c, consensus 60c 10/15/20 WNS Holdings sees FY21 adjusted EPS $2.33-$2.48, consensus $2.33 10/15/20 WNS Holdings reports Q2 adjusted EPS 73c, consensus 53c

Hot Stocks	500.com to purchase 1,923 S17 Bitcoin mining machines from BitDeer for $4.9M » 05:27 02/26/21 02/26 05:27 02/26/21 05:27 WBAI 500.com $20.52 / -1.31 (-6.00%) 500.com announced that it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Periodicals On The Fly Options WBAI 500.com $20.52 / -1.31 (-6.00%) 02/17/21 500.com rises 13.4% 02/16/21 500.com rises 39.5% 02/16/21 500.com rises 66.7% 02/16/21 500.com rises 69.4% WBAI 500.com $20.52 / -1.31 (-6.00%) 01/11/21 Muddy Waters circles back on 500.com after shorting in 2014 WBAI 500.com $20.52 / -1.31 (-6.00%) 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 02/16/21 Fly Intel: Pre-market Movers 01/11/21 Fly Intel: Pre-market Movers WBAI 500.com $20.52 / -1.31 (-6.00%) 01/20/21 Largest borrow rate increases among liquid names 01/19/21 Largest borrow rate increases among liquid names
Downgrade	Salmar downgraded to Hold from Buy at Pareto » 05:26 02/26/21 02/26 05:26 02/26/21 05:26 SALRF Salmar $0.00 / + (+0.00%) Pareto analyst Carl-Emil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SALRF Salmar $0.00 / + (+0.00%) 05:22 Today DNB Markets Salmar downgraded to Hold from Buy at DNB Markets 05:18 Today Danske Bank Salmar downgraded to Hold from Buy at Danske Bank 01/11/21 Danske Bank Salmar upgraded to Buy from Hold at Danske Bank 01/07/21 Pareto Salmar upgraded to Buy from Hold at Pareto
Upgrade	HSBC upgraded to Hold from Sell at Societe Generale » 05:26 02/26/21 02/26 05:26 02/26/21 05:26 HSBC HSBC $30.17 / -0.185 (-0.61%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HSBC HSBC $30.17 / -0.185 (-0.61%) 01/15/21 Chubb CFO Philip Bancroft to retire, Peter Enns to succeed 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 12/15/20 ECB asks banks to refrain from or limit dividends until September 2021 11/29/20 Fly Intel: Top five weekend stock stories HSBC HSBC $30.17 / -0.185 (-0.61%) 02/25/21 Berenberg HSBC price target raised to 400 GBp from 380 GBp at Berenberg 02/24/21 Barclays HSBC price target raised to 440 GBp from 400 GBp at Barclays 02/24/21 Credit Suisse HSBC price target raised to 400 GBp from 370 GBp at Credit Suisse 02/24/21 Morgan Stanley HSBC price target raised to 430 GBp from 410 GBp at Morgan Stanley HSBC HSBC $30.17 / -0.185 (-0.61%) 10/27/20 HSBC reports Q3 EPS 7c vs. 15c last year HSBC HSBC $30.17 / -0.185 (-0.61%) 02/19/21 HSBC doesn't have to hand over documents to Huawei CFO, WSJ reports 01/27/21 U.K. taps HSBC, JPMorgan to advise on first 'green' bond, Reuters says 01/10/21 HSBC to face shareholder heat on fossil fuels in AGM vote, Reuters says 11/29/20 HSBC considers exit from U.S. retail banking, FT reports HSBC HSBC $30.17 / -0.185 (-0.61%) 10/16/20 The Intersection: Crypto and Wall Street This Week 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 09/21/20 Fly Intel: Pre-market Movers HSBC HSBC $30.17 / -0.185 (-0.61%) 01/07/21 HSBC call volume above normal and directionally bullish 12/09/20 Unusually active option classes on open December 9th 12/04/20 Unusually active option classes on open December 4th 11/09/20 HSBC call volume above normal and directionally bullish
Initiation	PetroTal initiated with a Buy at Stifel » 05:25 02/26/21 02/26 05:25 02/26/21 05:25 PTALF PetroTal $0.00 / + (+0.00%) Stifel initiated coverage… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	Veolia Environment upgraded to Buy from Hold at DZ Bank » 05:24 02/26/21 02/26 05:24 02/26/21 05:24 VEOEY Veolia Environment $0.00 / + (+0.00%) DZ Bank analyst Werner… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals VEOEY Veolia Environment $0.00 / + (+0.00%) 10/05/20 Engie accepts Veolia's offer to purchase its stake in Suez 10/05/20 Suez says Veolia press release 'misleading,' reports 'failure of discussions' 10/05/20 Veolia commits not to file hostile bid following sale of Engie's Suez stake 09/30/20 Engie welcomes improved Veolia offer, requests extension of expiry date VEOEY Veolia Environment $0.00 / + (+0.00%) 02/16/21 Berenberg Veolia Environment price target raised to EUR 30 from EUR 21 at Berenberg 01/12/21 Barclays Veolia Environment price target raised to EUR 22.50 from EUR 20 at Barclays 09/01/20 BofA Veolia Environment upgraded to Buy from Underperform at BofA 07/17/20 Deutsche Bank Veolia price target raised to EUR 18.50 from EUR 15.50 at Deutsche Bank VEOEY Veolia Environment $0.00 / + (+0.00%) 09/25/20 Veolia CEO to increase offer price for stake in Suez, Bloomberg reports

Downgrade	ISS downgraded to Hold from Buy at Danske Bank » 05:24 02/26/21 02/26 05:24 02/26/21 05:24 ISSDY ISS $0.00 / + (+0.00%) Danske Bank downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ISSDY ISS $0.00 / + (+0.00%) 02/03/21 Bryan Garnier ISS initiated with a Neutral at Bryan Garnier 11/27/20 Goldman Sachs ISS price target lowered to DKK 160 from DKK 170 at Goldman Sachs 11/18/20 UBS ISS price target raised to DKK 115 from DKK 95 at UBS 11/10/20 Morgan Stanley ISS price target lowered to DKK 75 from DKK 80 at Morgan Stanley
Hot Stocks	China Distance Education receives shareholder approval for going private deal » 05:24 02/26/21 02/26 05:24 02/26/21 05:24 DL China Distance Education $9.60 / -0.13 (-1.34%) China Distance Education… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly DL China Distance Education $9.60 / -0.13 (-1.34%) 12/01/20 China Distance Education enters merger agreement for going private trnsaction 08/26/20 China Distance Education CEO says Q3 revenue was within guidance range DL China Distance Education $9.60 / -0.13 (-1.34%) 08/26/20 China Distance Education reports Q3 EPS 9c, one estimate 6c DL China Distance Education $9.60 / -0.13 (-1.34%) 12/01/20 Fly Intel: Pre-market Movers
Downgrade	Fly Leasing downgraded to Hold from Buy at Deutsche Bank » 05:23 02/26/21 02/26 05:23 02/26/21 05:23 FLY Fly Leasing $12.42 / -0.19 (-1.51%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals FLY Fly Leasing $12.42 / -0.19 (-1.51%) 12/23/20 Fly Leasing rises 22.8% 09/28/20 Fly Leasing rises 19.2% FLY Fly Leasing $12.42 / -0.19 (-1.51%) 01/26/21 Cowen Fly Leasing price target raised to $13 from $9 at Cowen 01/25/21 Deutsche Bank Fly Leasing price target raised to $11 from $8.50 at Deutsche Bank 11/16/20 Deutsche Bank Fly Leasing price target lowered to $8.50 from $10 at Deutsche Bank 05/26/20 JPMorgan JPMorgan upgrades Fly Leasing with stock rally lagging peers FLY Fly Leasing $12.42 / -0.19 (-1.51%) 02/25/21 Fly Leasing reports Q4 adjusted EPS ($3.78), consensus (15c) 11/12/20 Fly Leasing reports Q3 adjusted EPS (30c), consensus 36c FLY Fly Leasing $12.42 / -0.19 (-1.51%) 12/23/20 Fly Leasing rallies after Airfinance Journal says considering sale
Downgrade	Salmar downgraded to Hold from Buy at DNB Markets » 05:22 02/26/21 02/26 05:22 02/26/21 05:22 SALRF Salmar $0.00 / + (+0.00%) DNB Markets analyst Stein… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SALRF Salmar $0.00 / + (+0.00%) 05:18 Today Danske Bank Salmar downgraded to Hold from Buy at Danske Bank 01/11/21 Danske Bank Salmar upgraded to Buy from Hold at Danske Bank 01/07/21 Pareto Salmar upgraded to Buy from Hold at Pareto 11/13/20 Danske Bank Salmar downgraded to Hold from Buy at Danske Bank
Downgrade	Saipem downgraded to Underperform from Neutral at Exane BNP Paribas » 05:21 02/26/21 02/26 05:21 02/26/21 05:21 SAPMY Saipem $0.00 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SAPMY Saipem $0.00 / + (+0.00%) 02/24/21 Perma-Pipe International announces contract award in excess of $5M SAPMY Saipem $0.00 / + (+0.00%) 01/26/21 Morgan Stanley Saipem price target raised to EUR 2.10 from EUR 1.90 at Morgan Stanley 01/06/21 JPMorgan Saipem price target raised to EUR 2.90 from EUR 2.50 at JPMorgan 11/20/20 JPMorgan Saipem price target lowered to EUR 2.50 from EUR 3.70 at JPMorgan 11/17/20 Morgan Stanley Saipem price target raised to EUR 1.90 from EUR 1.75 at Morgan Stanley

Events

Earnings calls, analyst events, roadshows and more

ENDP
Today at 07:30

Endo - ENDP Conference Calls
MRSN
Today at 08:00

Mersana Therapeutics - MRSN Conference Calls
VST
Today at 08:00

Vistra Energy - VST Conference Calls
REPH
Today at 08:00

Recro Pharma - REPH Conference Calls
ACMR
Today at 08:00

ACM Research - ACMR Conference Calls
AGO
Today at 08:00

Assured Guaranty - AGO Conference Calls
EVRG
Today at 08:00

Evergy - EVRG Conference Calls
JRVR
Today at 08:00

James River Group - JRVR Conference Calls
BRFS
Today at 08:00

BRF S.A. - BRFS Conference Calls
FTAI
Today at 08:00

Fortress Transportation - FTAI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	OUT X OUT Outfront Media Block Trade Managers: Morgan Stanley Priced at: $22.00 1.76M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BWAY X BWAY Brainsway Spot Secondary Managers: Oppenheimer Priced at: $8.50 4.62M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CCL X CCL Carnival Spot Secondary Managers: Goldman Sachs Priced at: $25.10 40.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PAVM X PAVM PAVmed Spot Secondary Managers: Cantor Fitzgerald Priced at: $4.60 9.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SHOP X SHOP Shopify Spot Secondary Managers: Citi, Credit Suisse & Goldman Sachs Priced at: $1,315 1.18M Shares
Tues	DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $42.70 11M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BCTX X BCTX BriaCell IPO Managers: ThinkEquity Priced at: $4.25 5.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BFRA X BFRA Biofrontera Secondary Managers: Benchmark, LAKE Priced at: $6.68 1.334M Shares FRPT X FRPT Freshpet Secondary Managers: BofA, Baird & Truist Priced at: $143.00 2.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CELC X CELC Celcuity Spot Secondary Managers: Craig-Hallum Priced at: $14.00 1.714M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	SCR X SCR Score Media Secondary Managers: Morgan Stanley, Credit Suisse, Canaccord & Macquarie Priced at: $27.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TROX X TROX Tronox Secondary Managers: JPMorgan, BofA, Deutsche Bank, Morgan Stanley Priced at: $18.25 19.11M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ADMS X ADMS Adamas Pharmaceuticals Spot Secondary Managers: SVB Leerink, William Blair & JMP Securities Priced at: $4.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APEI X APEI American Public Education Spot Secondary Managers: Truist & William Blair Priced at: $25.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GPRE X GPRE Green Plains Spot Secondary Managers: Jefferies & BofA Priced at: $23.00 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IFRX X IFRX InflaRx Spot Secondary Managers: Guggenheim & Raymond James Priced at: $5.00 15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ITP X ITP IT Tech Packaging Spot Secondary Managers: Maxim Priced at: $.75 26.667M Shares RCEL X RCEL Avita Medical Spot Secondary Managers: Piper Sandler & Cowen Priced at: $21.50 2.795M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	GTES X GTES Gates Industrial Secondary Managers: Citi & Evercore ISI, Barclays, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital, UBS, Baird, Nomura, Wells Fargo, Guggenheim, KeyBanc Priced at: $15.00 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	APAM X APAM Artisan Partners Spot Secondary Managers: BofA $49.38 1.11M Shares
Thurs	FOCS X FOCS Focus Financial Spot Secondary Managers: Goldman Sachs, BofA, KKR & SPC Capital Markets $52.27 7M Shares STRM X STRM Streamline Health Spot Secondary Managers: Craig-Hallum $1.87
Fri	No deals

View All Syndicate Announcements »

Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program

TODAY'S FREE FLY STORIES

Get Full Fly Access